Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07613502 · ClinicalTrials.gov registry record · NA
Bio Leg: Advancing Mobility (BAM)
A NA study, sponsored by University of Florida.
- Recruiting
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT07613502 is a NA study that is actively recruiting participants, run by University of Florida. The registered enrollment target is 12 participants.
The verdict
NCT07613502, a NA study, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
Following transfemoral amputation, regaining functional mobility, particularly the ability to navigate curbs, ramps, long distances, and the ability to stand is challenging and often unattainable. Use of advanced prosthetic limb technology can dramatically influence mobility outcomes. The purpose of this study is to compare walking function in individuals with transfemoral amputations who are current users of the C-leg (micro-processor controlled prosthetic knee; current clinical standard) to function achieved when using the Bio Leg powered micro-processor prosthetic knee.
Interventions
- DEVICE Bio Leg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2026-06-01 |
| Est. Completion | 2028-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07613502
The ClinicalTrials.gov registry entry for NCT07613502 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bio Leg is the first listed.
NCT07613502 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07613502 about?
NCT07613502 is a clinical study titled "Bio Leg: Advancing Mobility (BAM)". Following transfemoral amputation, regaining functional mobility, particularly the ability to navigate curbs, ramps, long distances, and the ability to stand is challenging and often unattainable. Use of advanced prosthetic limb technology can dramatically influence mobility outcomes. The purpose of...
What is the current status of trial NCT07613502?
This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2026-06-01. Estimated completion is 2028-07.
What interventions are being tested in trial NCT07613502?
The interventions under investigation include: Bio Leg (DEVICE).
Who is sponsoring clinical trial NCT07613502?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.